Nuclera joins Tech Nation’s Future Fifty program

Nuclera recognized as one of UK’s most exciting growth stage companies.

Bruker to buy cell biology company PhenomeX for $108m

PhenomeX offers single-cell biology research tools for delivering insights into cellular function. Credit: Arek Socha from Pixabay. Bruker has entered a definitive agreement to acquire

August 18, 2023

AI model can accurately screen for post-traumatic stress disorder after childbirth

A generative artificial intelligence (AI) model that can analyze the narrative accounts of women who have undergone recent childbirth has shown the ability to accurately

April 13, 2024

FDA rejects Coherus’ reworked Neulasta biosimilar due to third-party inspections

The FDA has rejected Coherus BioSciences’ new presentation for its Udenyca (pegfilgrastim-cbqv) biosimilar due to an inspection at one of its contractors. Coherus said the

September 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.